NO812233L - Nye peptider og anvendelse av peptider. - Google Patents

Nye peptider og anvendelse av peptider.

Info

Publication number
NO812233L
NO812233L NO812233A NO812233A NO812233L NO 812233 L NO812233 L NO 812233L NO 812233 A NO812233 A NO 812233A NO 812233 A NO812233 A NO 812233A NO 812233 L NO812233 L NO 812233L
Authority
NO
Norway
Prior art keywords
glucagon
compounds
denotes
formula
thr
Prior art date
Application number
NO812233A
Other languages
English (en)
Norwegian (no)
Inventor
Behrend Friedrich Lundt
Karin Damm Joergensen
Nils Langeland Johansen
Frederik Christian Groenvald
Erik Kai Frandsen
Alister James Moody
Jan Markussen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of NO812233L publication Critical patent/NO812233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO812233A 1980-07-01 1981-06-30 Nye peptider og anvendelse av peptider. NO812233L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK283180A DK283180A (da) 1980-07-01 1980-07-01 Polypeptider og derivater deraf

Publications (1)

Publication Number Publication Date
NO812233L true NO812233L (no) 1982-01-04

Family

ID=8116221

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812233A NO812233L (no) 1980-07-01 1981-06-30 Nye peptider og anvendelse av peptider.

Country Status (13)

Country Link
US (1) US4598065A (OSRAM)
EP (1) EP0044168B1 (OSRAM)
JP (1) JPS5746950A (OSRAM)
AT (1) ATE13433T1 (OSRAM)
AU (1) AU548677B2 (OSRAM)
CA (1) CA1185180A (OSRAM)
DE (1) DE3170587D1 (OSRAM)
DK (1) DK283180A (OSRAM)
FI (1) FI812044L (OSRAM)
GR (1) GR74361B (OSRAM)
NO (1) NO812233L (OSRAM)
PT (1) PT73291B (OSRAM)
ZA (1) ZA813803B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ202757A (en) * 1981-12-23 1985-11-08 Novo Industri As Peptides and medicaments
GB2123836A (en) * 1981-12-28 1984-02-08 Novo Industri As Use of peptides as a medicament
DK27885A (da) * 1985-01-22 1986-07-23 Novo Industri As Fremstilling af peptider
US5120712A (en) * 1986-05-05 1992-06-09 The General Hospital Corporation Insulinotropic hormone
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US7138486B2 (en) 1986-05-05 2006-11-21 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
CA1341320C (en) * 1986-05-05 2001-11-20 Joel Habener Insulinotropic hormone
US5118666A (en) * 1986-05-05 1992-06-02 The General Hospital Corporation Insulinotropic hormone
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
WO1990011296A1 (en) * 1989-03-20 1990-10-04 The General Hospital Corporation Insulinotropic hormone
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
GB9409496D0 (en) 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
WO2007028394A2 (en) * 2005-09-08 2007-03-15 Gastrotech Pharma A/S Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use

Also Published As

Publication number Publication date
PT73291B (en) 1983-05-11
FI812044L (fi) 1982-01-02
DE3170587D1 (en) 1985-06-27
AU548677B2 (en) 1986-01-02
ATE13433T1 (de) 1985-06-15
EP0044168B1 (en) 1985-05-22
CA1185180A (en) 1985-04-09
FI812044A7 (fi) 1981-01-02
GR74361B (OSRAM) 1984-06-28
PT73291A (en) 1981-07-01
US4598065A (en) 1986-07-01
JPS5746950A (en) 1982-03-17
AU7236481A (en) 1982-01-07
EP0044168A1 (en) 1982-01-20
DK283180A (da) 1982-01-02
ZA813803B (en) 1982-06-30

Similar Documents

Publication Publication Date Title
NO812233L (no) Nye peptider og anvendelse av peptider.
US5084555A (en) An octapeptide bombesin analog
US5877277A (en) Octapeptide bombesin analogs
EP0438519B1 (en) Therapeutic peptides
US4758550A (en) Calcitonin derivatives
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JPH08510205A (ja) Ｙｙペプチドのアナログとその用途
NZ202757A (en) Peptides and medicaments
CZ281507B6 (cs) Syntetické peptidy, biologický aktivní fragment a jejich netoxické soli
NO315611B1 (no) Forbindelser med veksthormonfrigjörende egenskaper, farmasöytiske preparater som omfatter dem, samt anvendelse derav til fremstilling avmedikamenter
JPS6218560B2 (OSRAM)
NO800743L (no) Nye peptider og fremgangsmaate til deres fremstilling
NZ195817A (en) Acylpeptide derivatives of somatostatin,and pharmaceutical compositions
US4490364A (en) CCK Agonists II
AU2004232314A1 (en) Peptide vectors
EP2460826B1 (en) Motilin-like peptide compound having transmucosal absorbability imparted thereto
US5620959A (en) Bombesin antagonists
KR960013387B1 (ko) 용해성이 개선돤 고나도리베린의 동족체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
JP2809403B2 (ja) 治療用ソマトスタチンアナログ化合物
US5461035A (en) Short peptides with insulin activity
US20090281032A1 (en) Modified CCK peptides
WO1991006563A1 (en) Reduced irreversible bombesin antagonists
KR0142195B1 (ko) 고나도리베린의 경쟁적 길항제
US4460576A (en) Peptide and hormone agent containing the same as effective ingredient